The stromal tumor is the most common mesenchymal tumor of the gastrointestinal tract. Surgical resection is the first-line therapy for operable lesions, however for inoperable imatinib is an effective therapy. In this setting a patient has been operated after a remarkable response to imatinib, used as both neoadjuvant and adjuvant. This approach led to a disease-free condition without toxicity and complications.
|Translated title of the contribution||Surgical resection of gastrointestinal stromal tumor after treatment with imatinib: clinical case|
|Title of host publication||I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.]|
|Publication status||Published - 2005|